Fusion Antibodies (FAB)

Sector:

Health Care

Index:

FTSE AIM All-Share

 62.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 145.00
  • 52 Week Low: 58.50
  • Currency: UK Pounds
  • Shares Issued: 26.01m
  • Volume: 0
  • Market Cap: £16.26m
  • RiskGrade: 464

FAB Overview

Fusion Antibodies is a Collaborative Research Organisation (CRO) with its headquarters in Northern Ireland. We are world leaders in antibody development services specializing in the discovery, engineering and supply of pre-clinical biologics through to clinical Cell Line Development.

Key Personnel

CFO: James Alexander Fair
Chairman: Simon Gordon Douglas
Chief Scientific Officer: Richard John Buick
Independent Non-Executive Director: Timothy William Watts
Senior Independent Director: Sonya Maria Ferguson
Non-Executive Dir: Matthew Baker, Colin Walsh

Contact Details

Address: C/O Tughans Solicitors, Marlborough House, 30 Victoria Street, Belfast, Ireland, United Kingdom , BT1 3GG
Website: https://www.fusionantibodies.com/

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BDQZGK16

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

FAB Market Data

Currency UK Pounds
Share Price 62.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 145.00
52 Week Low 58.50
Volume 0
Shares Issued 26.01m
Market Cap £16.26m
RiskGrade 464

FAB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.41% below the market average34.41% below the market average34.41% below the market average34.41% below the market average34.41% below the market average
28.21% above the sector average28.21% above the sector average28.21% above the sector average28.21% above the sector average28.21% above the sector average
Price Trend
86.96% below the market average86.96% below the market average86.96% below the market average86.96% below the market average86.96% below the market average
75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average
Income Not Available
Growth
32.60% above the market average32.60% above the market average32.60% above the market average32.60% above the market average32.60% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

FAB Dividends

No dividends found

Trades for --2022

Time Volume / Share Price
0 @ 0.000p

FAB Key Personnel

Chair Simon Gordon Douglas
CFO James Alexander Fair

Top of Page